Sinphar Pharmaceutical Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2019
May 12, 2019 at 03:16 pm EDT
Share
Sinphar Pharmaceutical Co.,Ltd. announced earnings results for the first quarter ended March 31, 2019. For the first quarter, the company announced sales was TWD 572.873 million compared to TWD 560.126 million a year ago. Operating loss was TWD 19.783 million compared to TWD 3.646 million a year ago. Net income was TWD 14.292 million compared to TWD 16.753 million a year ago. Basic earnings per share was TWD 0.09 compared to TWD 0.1 a year ago.
Sinphar Pharmaceutical Co., Ltd. is principally engaged in the research and development, manufacture and distribution of pharmaceuticals. The Company is also engaged in the sales of functional food products. The Companyâs principal products include ointment, gel, cream, hard and soft capsules, sugar-coated tablets, film-coated tablets, suppositories, powders and granules, lozenges, soft candies, oral and topical liquid medicines, injections, dry medicated powers, functional food products, medical equipment and cosmetics. The Company mainly sells its products to hospitals, drug stores, clinics, dealers and distributors. Its primary markets are located in Taiwan and overseas countries.
SINPHAR PHARMACEUTICAL CO.,LTD. 
